Sironi, L <br/><br/>
Plasminogen activator inhibitor type-1 synthesis and mRNA expression in HepG2 cells are regulated by VLDL.  [electronic resource] 

 -  Arteriosclerosis, thrombosis, and vascular biology  Jan 1996 
 - 89-96 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't 
<br/><br/><label>ISSN: </label>1079-5642 
<br/><br/><label>Standard No.: </label>10.1161/01.atv.16.1.89  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Carcinoma, Hepatocellular--metabolism<br/>Culture Media, Conditioned<br/>Gene Expression Regulation--drug effects<br/>Humans<br/>Lipoproteins, VLDL--pharmacology<br/>Liver Neoplasms--metabolism<br/>Plasminogen Activator Inhibitor 1--biosynthesis<br/>RNA, Messenger--metabolism<br/>Receptors, LDL--physiology<br/>Triglycerides--metabolism<br/>Tumor Cells, Cultured